Aliski William 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Jun 28, 2021
Insider Transaction Report
Form 4
Aliski William
Director
Transactions
- Award
Common Stock
2021-06-24+2,145→ 66,849 total - Award
Stock Option (Right to Buy)
2021-06-24+4,125→ 4,125 totalExercise: $93.20Exp: 2031-06-24→ Common Stock (4,125 underlying)
Holdings
- 70,350(indirect: By Trust)
Common Stock
- 10,456(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022.
- [F2]These shares are held in a trust for the benefit of the Reporting Person's spouse and children. The Reporting Person's spouse and nephew are trustees of the trust.
- [F3]These shares are held in a grantor retained annuity trust. The Reporting Person is the trustee of the trusts.
- [F4]The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022.